Fundraising Fox
🦊/People
Sign in

Xueming Qian

Founder

Founder at Transcenta Holding

Princeton, New Jersey, United States

FoundedTranscenta Holding

Find your path to Xueming

352 people in our graph share verified history with Xueming — schools, employers, funds. One of them is your warm intro.

David KaufmanunlockedXueming: together at The Rockefeller University (1994–1995)
×7Xueming: together at Amgen
×3Xueming: together at Fudan University
Xueming: together at Columbia University Vagelos College of Physicians and Surgeons

About

Xueming Qian is the Founder, Chairman, and CEO of Transcenta, a biopharmaceutical company he established in 2013 as MABSPACE, focused on developing medicines for cancer, bone, and kidney diseases. Trained in neuroscience, he previously worked on antibody-based drug development at Amgen from 1997 to 2010. Transcenta employs approximately 300 scientists across sites in the United States and China and is developing a pipeline of 10 antibody therapeutic candidates.

Founder at Transcenta Holding

Intro paths

→

In turn, Xueming can intro founders to Transcenta Holding's investors below.

Transcenta Holding's investors · 3

ARCH Venture PartnersChicago · $50K – $250M checksChina Structural Reform FundBeijingFortune Venture CapitalShenzhen · $425K – $73M checks

Experience

  1. TranscentaFounder, Chairman and CEOcurrent2024 — presentPrinceton, New Jersey, United States
  2. TranscentaFounder and CEO2019 — 2024Princeton, New Jersey, United States
  3. Mabspace BiosciencesFounder, Chairman and CEO2012 — 2018Suzhou, Jiangsu, China
  4. Shenogen Pharma GroupConsultant2012 — 2013Beijing, China
  5. Shenogen Pharma GroupSVP & Head, Research & Development；2010 — 2012Beijing， China
  6. AmgenPrincipal Scientist2005 — 2010
  7. Amgen Inc.Senior Reseach Scientist2000 — 2005
  8. Amgen Inc.Postdoc Fellow1997 — 2000

Skills & more

Molecular Biology62Drug Discovery99Cancer32Cell25Therapeutics2Assay Development35Drug Development75Antibodies17Neuroscience6Genomics17Stem Cells6Laboratory13
+8 moreTechnology TransferBiopharmaceuticalsBiochemistryClinical TrialsSmall MoleculesGLPBiotechnologyOncology

Languages Chinese

From Xueming's professional profile.

Frequently asked questions

Who is Xueming Qian?
Xueming Qian is the Founder, Chairman, and CEO of Transcenta, a biopharmaceutical company he established in 2013 as MABSPACE, focused on developing medicines for cancer, bone, and kidney diseases. Trained in neuroscience, he previously worked on antibody-based drug development at Amgen from 1997 to 2010. Transcenta employs approximately 300 scientists across sites in the United States and China and is developing a pipeline of 10 antibody therapeutic candidates.
Where does Xueming Qian work?
Xueming Qian is Founder of Transcenta Holding.
What companies did Xueming Qian found?
Xueming Qian founded Transcenta Holding.
Where did Xueming Qian go to school?
Xueming Qian studied at Albany Medical College (Ph.D., Neuroscience and Pharmacology); The Rockefeller University (Molecular Neuroscience); Columbia University Vagelos College of Physicians and Surgeons (M.A., Neuroscience / Physiology).

Founder mafias

Same school

Shared employers